SCHEMBL3171012

SCHEMBL3171012

Cc1c(OC2CCN(OC(=O)OC(C)C)CC2)ccnc1Oc1cc(F)c(CCOC(C)C)cc1F

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 12/20 0.40
CYP2C9 P11712 1/20 0.40
ACACB O00763 5/20 0.33
GPR6 P46095 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3160713 0.89 GPR119 (0.44) GPR119CYP2C9
SCHEMBL391003 0.89 GPR119 (0.52) GPR119CYP2C9
SCHEMBL3160341 0.79 GPR119 (0.42) GPR119CYP2C9ACACBGPR6
SCHEMBL386703 0.78 GPR119 (0.56) GPR119CYP2C9
SCHEMBL3169215 0.78 GPR119 (0.54) GPR119CYP2C9
SCHEMBL3162014 0.77 GPR119 (0.40) GPR119CYP2C9GPR6
SCHEMBL3166965 0.76 GPR119 (0.47) GPR119CYP2C9ACACB
SCHEMBL3169834 0.76 GPR119 (0.45) GPR119CYP2C9
SCHEMBL3168299 0.76 GPR119 (0.55) GPR119CYP2C9ACACB
SCHEMBL3160967 0.75 GPR119 (0.54) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644357-B9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2010-03-24 EP claimed
EP-1644357-B1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2007-12-12 EP claimed